Broadening authentic and context learning in clinical pharmacology education [0.03%]
临床药理学教育中真实性和情境化学习的拓展
M O Reumerman,R Sultan,M C Richir et al.
M O Reumerman et al.
Simulation of Imatinib Pharmacokinetics in pregnant women with chronic myeloid leukemia in the third trimester [0.03%]
模拟慢性髓性白血病孕妇三期伊马替尼药代动力学过程
Paola Mian,Christianne A R Lok,Anouk E W K Dontje et al.
Paola Mian et al.
Purpose To simulate different dosing regimens of imatinib in third trimester pregnant women with CML that could meet plasma exposure targets for efficacy (Cmin≥1000 ng/mL) without compromising on fetal safety risk. ...
Comment on "CYP2C19 genotyping and mavacamten: predicting outcomes in normal, intermediate and rapid metabolisers in obstructive hypertrophic cardiomyopathy" [0.03%]
关于"CYP2C19基因分型与mavacamten：预测阻塞性肥厚性心肌病正常代谢者、中间代谢者和快速代谢者的结局"的评论
Kotina Shridevi,Megha Doiphode,Rakhi Mishra et al.
Kotina Shridevi et al.
Trends in ADR reporting' and the missing context: COVID-19, LMICs, and sociodemographic blind spots [0.03%]
ADR报告趋势及其缺失的背景：新冠肺炎、LMIC和人口统计学盲点
Talha Ali,Muhammad Salman,Mateen Khan
Talha Ali
Delayed gastric emptying and antiseizure medication absorption: a potential pharmacokinetic consideration for GLP-1/GIP receptor agonists [0.03%]
胃排空延迟和抗惊厥药物吸收：GLP-1 / GIP受体激动剂的潜在药代动力学问题
Rafael Batista João,Paulo César Ragazzo
Rafael Batista João
Cost-effectiveness of sofosbuvir- ledipasvir for Hepatitis C treatment: a systematic review [0.03%]
索磷布韦维帕他韦治疗丙型肝炎的成本效益：系统评价
Nasim Jaberi,Somayeh Afshari,Farhad Khalili et al.
Nasim Jaberi et al.
Systematic review and first meta-analysis of the efficacy and safety of gemcitabine-cisplatin combined with paclitaxel in patients with advanced biliary tract cancer [0.03%]
吉西他滨联合顺铂对比吉西他滨单药治疗局部晚期/转移性胆系肿瘤患者的系统评价和meta分析
Gang Zhu,Shenglan Li,Yan Zhang et al.
Gang Zhu et al.
Authors' reply to "Outcomes for metastatic triple-negative breast cancer patients treated with sacituzumab govitecan in clinical studies and real-world studies: a single-arm meta-analysis" [0.03%]
替雷利珠单抗治疗转移性三阴性乳腺癌患者临床研究和真实世界研究结果的作者回信：一项单臂meta分析
Shuang Liang,Weiwei Liao,Junhao Jiang et al.
Shuang Liang et al.
A systematic review and meta-analysis of exposure-response analysis of osimertinib in patients with non-small-cell lung cancer [0.03%]
奥希替尼治疗非小细胞肺癌的剂量效应系统评价和meta分析
Weifeng Shao,Jingyi Yang,Liying Wu et al.
Weifeng Shao et al.
Population pharmacokinetic modeling and Monte Carlo simulation-based dosing optimization of trimethoprim-sulfamethoxazole in critically ill patients [0.03%]
重症患者使用复方新诺明的群体药代动力学研究及给药优化方案模拟分析
Min Wang,Chen Li,Xiangxiang Fu et al.
Min Wang et al.